Atea Pharmaceuticals, Inc. Increase (Decrease) in Accounts Payable
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-12
- Atea Pharmaceuticals, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $612.00K, a 58.00% decline year-over-year.
- Atea Pharmaceuticals, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$3.50M, a 219.46% decline year-over-year.
- Atea Pharmaceuticals, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $9.43M.
- Atea Pharmaceuticals, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$5.33M, a 1791.75% decline year-over-year.
- Atea Pharmaceuticals, Inc. increase (decrease) in accounts payable for fiscal 2025 was $8.49M, a 4019.90% increase from fiscal 2024.
- Atea Pharmaceuticals, Inc. increase (decrease) in accounts payable for fiscal 2024 was $206.00K, a 87.89% decline from fiscal 2023.
- Atea Pharmaceuticals, Inc. increase (decrease) in accounts payable for fiscal 2023 was $1.70M.
- Atea Pharmaceuticals, Inc. increase (decrease) in accounts payable for fiscal 2022 was -$1.98M, a 119.27% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $612.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$2.89M 10-Q · filed 2026-08-12 | $6.54M derived: sum of 3 quarters · filed 2026-08-12 | $1.21M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$3.50M 10-Q · filed 2026-05-12 | $5.93M derived: sum of 2 quarters · filed 2026-05-12 | $602.00K derived: sum of 3 quarters · filed 2026-05-12 | $2.06M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $9.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $4.10M derived: sum of 2 quarters · filed 2026-03-05 | $5.56M derived: sum of 3 quarters · filed 2026-08-12 | $8.49M 10-K · filed 2026-03-05 |
| 2025-09-30 | -$5.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$3.87M derived: sum of 2 quarters · filed 2026-08-12 | -$943.00K 10-Q · filed 2025-11-12 | -$2.27M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $4.39M 10-Q · filed 2026-08-12 | $3.06M derived: sum of 3 quarters · filed 2026-08-12 | $3.37M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $2.93M 10-Q · filed 2026-05-12 | $1.60M derived: sum of 2 quarters · filed 2026-05-12 | $1.92M derived: sum of 3 quarters · filed 2026-05-12 | -$13.75M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$1.01M derived: sum of 2 quarters · filed 2026-03-05 | -$16.68M derived: sum of 3 quarters · filed 2026-03-05 | $206.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $315.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$15.35M derived: sum of 2 quarters · filed 2025-11-12 | $1.53M 10-Q · filed 2025-11-12 | $5.39M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$15.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.22M 10-Q · filed 2025-08-07 | $5.08M derived: sum of 3 quarters · filed 2025-08-07 | $1.51M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $16.89M 10-Q · filed 2025-05-12 | $20.74M derived: sum of 2 quarters · filed 2025-05-12 | $17.18M derived: sum of 3 quarters · filed 2025-05-12 | $20.44M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $290.00K derived: sum of 2 quarters · filed 2025-03-06 | $3.55M derived: sum of 3 quarters · filed 2025-03-06 | $1.70M 10-K · filed 2025-03-06 |
| 2023-09-30 | -$3.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$305.00K derived: sum of 2 quarters · filed 2024-11-07 | -$2.16M 10-Q · filed 2024-11-07 | -$723.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $3.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $1.41M 10-Q · filed 2024-08-07 | $2.84M derived: sum of 3 quarters · filed 2024-08-07 | -$9.92M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$1.85M 10-Q · filed 2024-05-14 | -$418.00K derived: sum of 2 quarters · filed 2024-05-14 | -$13.19M derived: sum of 3 quarters · filed 2024-05-14 | -$2.96M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$11.33M derived: sum of 2 quarters · filed 2024-02-28 | -$1.11M derived: sum of 3 quarters · filed 2024-02-28 | -$1.98M 10-K · filed 2024-02-28 |
| 2022-09-30 | -$12.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$2.54M derived: sum of 2 quarters · filed 2023-11-08 | -$3.42M 10-Q · filed 2023-11-08 | -$21.07M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $10.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $9.35M 10-Q · filed 2023-08-08 | -$8.30M derived: sum of 3 quarters · filed 2023-08-08 | $3.18M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$877.00K 10-Q · filed 2023-05-08 | -$18.53M derived: sum of 2 quarters · filed 2023-05-08 | -$7.04M derived: sum of 3 quarters · filed 2023-05-08 | $5.68M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | -$17.66M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$6.17M derived: sum of 2 quarters · filed 2023-02-28 | $6.56M derived: sum of 3 quarters · filed 2023-02-28 | $10.29M 10-K · filed 2023-02-28 |
| 2021-09-30 | $11.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $24.21M derived: sum of 2 quarters · filed 2022-11-07 | $27.95M 10-Q · filed 2022-11-07 | $23.77M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $12.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $16.46M 10-Q · filed 2022-08-08 | $12.28M derived: sum of 3 quarters · filed 2023-02-28 | $13.32M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $3.73M 10-Q · filed 2022-05-10 | -$445.00K derived: sum of 2 quarters · filed 2023-02-28 | $601.00K derived: sum of 3 quarters · filed 2023-02-28 | $3.39M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$4.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$3.13M derived: sum of 2 quarters · filed 2023-02-28 | -$338.00K derived: sum of 3 quarters · filed 2023-02-28 | -$488.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $3.84M derived: sum of 2 quarters · filed 2021-11-12 | $3.69M 10-Q · filed 2021-11-12 | $4.14M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $2.64M 10-Q · filed 2021-08-12 | $3.09M derived: sum of 3 quarters · filed 2022-02-28 | |
| 2020-03-31 | -$150.00K 10-Q · filed 2021-05-13 | $297.00K derived: sum of 2 quarters · filed 2022-02-28 | ||
| 2019-12-31 | $447.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $157.00K 10-K · filed 2022-02-28 | ||
| 2019-09-30 | -$290.00K 10-Q · filed 2020-12-10 | |||
| 2018-12-31 | -$90.00K 10-K · filed 2021-03-30 |